A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress Disorder

BACKGROUND: Anxiety and trauma-related disorders are among the most prevalent and disabling medical conditions in the United States, and posttraumatic stress disorder in particular exacts a tremendous public health toll. We examined the tolerability and anxiolytic efficacy of neuropeptide Y administ...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayed, Sehrish, Van Dam, Nicholas T, Horn, Sarah R, Kautz, Marin M, Parides, Michael, Costi, Sara, Collins, Katherine A, Iacoviello, Brian, Iosifescu, Dan V, Mathé, Aleksander A, Southwick, Steven M, Feder, Adriana, Charney, Dennis S, Murrough, James W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Regular Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795352/
https://www.ncbi.nlm.nih.gov/pubmed/29186416
http://dx.doi.org/10.1093/ijnp/pyx109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795352/
https://www.ncbi.nlm.nih.gov/pubmed/29186416
http://dx.doi.org/10.1093/ijnp/pyx109

Ejemplares similares